Particle.news
Clinical Trials American Cancer Society Epidemiology Grants Therapeutics Melanoma Treatments Charity Fundraising Drug Development Charity Immunotherapy Cell Biology Translational Medicine Study Findings Metabolic Dysfunction Studies Clinical Excellence Medical Facilities Recurrence Mice Studies Pediatric Cancer Memorial Sloan Kettering Cancer Center Advancements Treatment Optimizing Cancer Care Treatment Advances Effects of Fasting
Largest study to date confirms ctDNA as a strong prognostic tool for stage III melanoma, with researchers aiming to enhance test sensitivity for clinical use.
